Cite
HARVARD Citation
Calleja, J. et al. (n.d.). Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis. Liver international. pp. 90-100. [Online].